A 24-year-old woman is diagnosed with uncomplicated chlamydial cervicitis (confirmed by NAAT). She is not pregnant and has no drug allergies. What is the preferred first-line treatment?

Explanation

## First-Line Treatment of Uncomplicated Chlamydial Genital Infection **Key Point:** Doxycycline 100 mg orally twice daily for 7 days is the preferred first-line agent for uncomplicated chlamydial urogenital infection in non-pregnant, non-lactating adults, per CDC, WHO, and Indian guidelines. ### Why Doxycycline Is Preferred Over Azithromycin **High-Yield:** Recent evidence (2019–2023) has shifted preference from azithromycin to doxycycline: | Feature | Doxycycline | Azithromycin | |---------|-------------|---------------| | **Efficacy** | 95–97% cure rate | 95–97% cure rate (similar) | | **Resistance** | Minimal emerging resistance | **Increasing macrolide-resistant *C. trachomatis*** | | **Microbiological cure** | Superior tissue penetration, higher intracellular levels | Lower intracellular concentrations | | **Compliance** | Twice daily × 7 days | Single 1 g dose (better compliance) | | **Cost** | Inexpensive | More expensive | | **GI side effects** | Mild–moderate (nausea, photosensitivity) | Nausea, diarrhea, QT prolongation risk | | **Pregnancy** | **Contraindicated** | Safe (Category B) | **Clinical Pearl:** CDC updated its 2021 STI treatment guidelines to recommend **doxycycline as first-line** over azithromycin, citing emerging macrolide resistance and superior microbiological outcomes. This reflects real-world resistance trends in *Chlamydia trachomatis*. ### Mechanism of Action Doxycycline is a tetracycline that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, achieving high intracellular concentrations essential for eliminating *C. trachomatis* from epithelial cells. ### Why Other Agents Are Not First-Line **Azithromycin (Option 0):** - Once first-line due to single-dose convenience - Emerging macrolide resistance in *C. trachomatis* (5–15% in some regions) - Now reserved for **pregnancy** and **penicillin allergy** scenarios - CDC 2021 downgraded it to alternative status **Erythromycin (Option 2):** - Older macrolide with poor GI tolerability - Lower efficacy (~80–85%) than doxycycline or azithromycin - Reserved for pregnant women with penicillin allergy (though azithromycin is preferred) **Ofloxacin (Option 3):** - Fluoroquinolone; efficacy is adequate (~95%) - More expensive than doxycycline - Not recommended as first-line in current guidelines - Reserved for special circumstances (allergy, drug interactions) ### Concurrent Gonorrhea Coverage Since *C. trachomatis* and *N. gonorrhoeae* co-infection occurs in 20–40% of cases, always add **ceftriaxone 250 mg IM single dose** if gonorrhea is not excluded (e.g., by Gram stain or NAAT). **Mnemonic:** **DOX-7** — **Dox**ycycline for 7 days is the modern standard for chlamydia in non-pregnant adults.